Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-24-004313

Chief Commercial Officer acquired 173,469 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2024-02-21 Grant or award +173,469 522,786 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2024-02-21 Grant or award · Stock Option (Right to Buy) +313,636 313,636 D: show line 2 in the form
Loading xslF345X05/form4.xml…